Health Care & Life Sciences » Biotechnology | BELLUS Health Inc.

BELLUS Health Inc.

BELLUS Health Inc.
Stock Exchange Other OTC
EPS
$0.07
Market Cap
$354.16 M
Shares Outstanding
66.87 M
Public Float
-
BELLUS Health Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
66.87 M
Public Float
-
BELLUS Health Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.09
Market Cap
CAD467.99 M
Shares Outstanding
158.11 M
Public Float
115.8 M

Profile

Address
275 Armand-Frappier boulevard
Laval Qu├ębec H7V 4A7
Canada
Employees -
Website http://www.bellushealth.com
Updated 07/08/2019
BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on April 12, 2012 and is headquartered in Laval, Canada.

Financials

View All

Francesco Bellini
Chairman
Roberto Bellini
President, Chief Executive Officer & Director